-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O3.6 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Innovative Approaches to GVHD Prevention and Treatment Clinically Relevant Abstract

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Translational Research, Clinical Research, GVHD, Diseases, Immune Disorders
Sunday, December 10, 2023: 4:30 PM-6:00 PM
Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
Moderators:
Muna Qayed, MD, Emory University and Masumi Ueda Oshima, MD, Fred Hutchinson Cancer Center
Disclosures:
Qayed: Vertex: Honoraria; Novartis: Honoraria.
This session includes clinical trials in GVHD prophylaxis and studies in GVHD risk prediction.
4:30 PM

Corey Cutler1, Haesook T. Kim, PhD2, Hassan El Banna1*, Elizabeth Halloran, BSN, RN1*, Emily Matozel1*, Vincent Ho, MD1*, John Koreth, MD, MBBS, PhD, DPhil1, Mahasweta Gooptu, MD1, Roman M. Shapiro, MD1, Amar H Kelkar, MD1, Christopher James Gibson, MD1, Carol Reynolds, PhD1*, Michela Ansuinelli, MD1*, Rayuko Tamada1*, Chloe Au1*, Zachariah Defilipp, MD3, Areej El-Jawahri, MD3, Yi-Bin Chen, MD, MS3, Najla El Jurdi, MD4, Daniel Weisdorf, MD5, Daniel R. Couriel, MD, MS, MBA6, Catherine J. Lee, MD7, Bita Sahaf, PhD, MSc8*, Juliana Craig9*, Kathleen Ji9*, Robert J. Soiffer, MD1, David B. Miklos, MD, PhD10, Joseph Antin, MD1* and Jerome Ritz, MD11

1Dana-Farber Cancer Institute, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Massachusetts General Hospital, Boston, MA
4Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, minneapolis, MN
5University of Minnesota, Minneapolis, MN
6Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
7Huntsman Cancer Institute, Salt Lake City, UT
8Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
9Stanford University Medical Center, Palo Alto, CA
10Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

4:45 PM

Hang Zhang, MD1*, Tian Dong, MD, PhD2*, Zhigang Liu, MD, PhD3*, Juan Xu, MD, PhD1*, Qiuhui Wu4*, Chuanli Zhang1*, Ting Liu, MD1 and Jie Ji, MD, PhD5*

1Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
2West China Hospital of Sichuan University, Chengdu, China, Chengdu, CHN
3Department of Hematology, West China Hospital/State Key Laboratory of Biotherapy, Chengdu, CHN
4West China Hospital, Chengdu, China
5Department of Hematology and Institute of Hematology, Department of Hematology, West China Hospital of Sichuan University, Chengdu, China

5:00 PM

Ramzi Abboud, MD1, Mark A. Schroeder, MD2, Michael P. Rettig, PhD3, Feng Gao, MD, PhD4*, Julie K. Ritchey3*, Camille N. Abboud, MD5, Iskra Pusic2, Peter Westervelt, MD2, Amanda F Cashen6, Matt Christopher, MD1, Armin Ghobadi, MD2, Ramzi Abboud, MD1, Keith Stockerl-Goldstein, MD7, Geoffrey L Uy, MD2, John F. DiPersio, MD, PhD3 and Leah Gehrs8*

1Washington University School of Medicine, St. Louis, MO
2Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Washington University School of Medicine, Saint Louis, MO
4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
5Washington University School of Medicine in Saint Louis, St. Louis, MO
6Washington Univ. School of Med., Saint Louis, MO
7Washington University Internal Medicine, Saint Louis, MO
8Washington University School of Medicine in St. Louis, St. Louis, MO

5:15 PM

Nicoletta Cieri, MD, PhD1,2,3, Nidhi Hookeri1,2*, Kari Stromhaug1,2*, Liang Li, MS4*, Julia Keating, MS5*, Jonathan Stevens6*, Kameron Kooshesh, MD3, Helen Ji2*, Gabrielle M. Hernandez1*, Jennifer Abelin, PhD1*, Susan Klaeger, PhD1*, Cleo Forman5*, Karl Clauser1*, Siranush Sarkizova, PhD1*, Giacomo Oliveira, PhD2,3*, Livius Penter, MD1,2,3, Haesook T. Kim, PhD5, William Lane, MD, PhD6*, Shuqiang Li, PhD1,7*, Kenneth J. Livak, PhD7*, Steven A. Carr, PhD1*, Derin B. Keskin7*, Vincent T. Ho, MD2,3*, Jerome Ritz, MD2,3, Robert J. Soiffer, MD2,3, Donna S. Neuberg, ScD5, Chip Stewart, PhD1*, Gad Getz, PhD3,4,8* and Catherine J Wu, MD1,2,3

1Broad Institute of MIT and Harvard, Cambridge, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Harvard Medical School, Boston, MA
4Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Brigham and Women's Hospital, Boston, MA
7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
8Cancer Center, Massachusetts General Hospital, Boston, MA

5:30 PM

Zachariah Defilipp, MD1, Haesook T. Kim, PhD2, Laura Knight1*, Suzanne O'Connor1*, Meghan White1*, Bhagirathbhai Dholaria, MBBS3, Mark A. Schroeder, MD4, Sumithira Vasu, MD, MBBS5, Sameem Abedin, MD6, Areej El-Jawahri, MD1, Steven McAfee, MD1*, Yi-Bin Chen, MD, MS1 and Gabriela S. Hobbs, MD1

1Massachusetts General Hospital, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
4Division of Oncology, Washington University School of Medicine, Saint Louis, MO
5The Ohio State University, Columbus, OH
6Medical College of Wisconsin, Milwaukee, WI

5:45 PM

Robert Zeiser, MD1, Domenico Russo, MD, PhD2*, Ron Ram, MD3, Shahrukh K Hashmi, MD, MPH4,5*, Ronjon Chakraverty, MD6*, Jan Moritz Middeke, MD7*, Maurizio Musso8*, Sebastian Giebel9*, Ant Uzay, MD10*, Peter Langmuir, MD11*, Nada Hamad, BSc MSc MBBS FRACP FRCPA12,13, Xuechan Li, PhD14*, Maanasa Gowda, PharmD14*, Tommaso Stefanelli, MD15*, Stephanie J. Lee16, Takanori Teshima, M.D., Ph.D.17 and Franco Locatelli, MD, PhD18

1Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
2Unit of Blood Diseases and Bone Marrow Transplantation, University of Brescia, ASST- Spedali Civili of Brescia, Brescia, Italy
3Bone Marrow Transplant Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates
5Department of Medicine, Mayo Clinic, Rochester, MN
6Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
7Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden and National Center for Tumor Diseases (NCT) Dresden, Desden, Germany
8UOC of Oncohematology and TMO, Oncology Department La Maddalena, Palermo, Italy
9Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
10Acibadem University Atakent Hospital, Bone Marrow Transplant Unit and Acibadem University Medical Faculty, Istanbul, Turkey
11Incyte Corporation, Wilmington, DE
12St Vincent's Hospital, Darlinghurst, NSW, Australia
13The University of New South Wales, Sydney, NSW, Australia
14Novartis Pharmaceuticals Corporation, East Hanover, NJ
15Novartis Pharma AG, Basel, Switzerland
16Fred Hutchinson Cancer Center, Seattle, WA
17Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
18Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, and Catholic University of the Sacred Heart, Rome, Italy

*signifies non-member of ASH